Clinical studies recruiting near Ulm

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Universitaetsklinikum Ulm · Eli Lilly and Company · NCT07218380 Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05755386 A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Investigational Site Number : 2760006 · Sanofi · NCT06867094 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Universitaetsklinikum Ulm · Pfizer · NCT07028853 A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 3 · University of Ulm · Takeda · NCT06747351 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · Universitätsklinikum Ulm · Princess Maxima Center for Pediatric Oncology · NCT05327894 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Universitaetsklinikum Ulm. ( Site 0601) · Merck Sharp & Dohme LLC · NCT06136559 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Universitaetsklinikum Ulm · Bristol-Myers Squibb · NCT07106762 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Universitaetsklinikum Ulm · Pfizer · NCT06758401 Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
Phase 3 · Universitätsklinik Ulm · AGO Study Group · NCT05009082 A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
Phase 3 · Investigational Site Number : 2760006 · Sanofi · NCT07190196 The Oxford Risk Factors And Non-Invasive Imaging Study
Phase N/A · University Hospital Ulm · University of Oxford · NCT05169333 A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Phase 2 · Universitaetsklinikum Ulm · Eli Lilly and Company · NCT07483099 - IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite Stable / Proficient Misma
Phase 2 · Universitätsklinikum Ulm · Institut für Klinische Krebsforschung IKF GmbH at Krankenhau · NCT06856837 Endometrial Cancer Lymphadenectomy Trial
NA · Universitätsklinikum Ulm, Universitätsfrauenklinik · Philipps University Marburg · NCT03438474 Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · New Ulm Medical Center · Alliance for Clinical Trials in Oncology · NCT07091617 Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone Lymphoma
Phase 3 · UNIV KLINIKUM ULM - INNERE MEDIZIN III - Hämatologie · The Lymphoma Academic Research Organisation · NCT06006117 A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary
Phase N/A · Herzklinik · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615 A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Pati
Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06581198 European Larynx Organ Preservation Study (ELOS) [MK-3475-C44]
Phase 2 · Universitätsklinikum Ulm / Ulm University Medical Center, Kl · University of Leipzig · NCT06137378 Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Phase N/A · New Ulm Medical Center · PrECOG, LLC. · NCT06538038 Registry for Patients With Lipodystrophy
Phase N/A · Dept for Pediatrics and Adolescent Medicine, University of U · University of Ulm · NCT03553420 A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Dia
Phase 3 · Universitaetsklinikum Ulm · Eli Lilly and Company · NCT07222332 A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Phase 2 · Investigational Site Number: 2760001 · Sanofi · NCT06958536 A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorecta
Phase 1 · Universitätsklinikum Ulm · Hoffmann-La Roche · NCT04929223 DEfeating PEnile CAncer-2
NA · University Hospital Ulm · University Hospital Tuebingen · NCT07378670 The Pancreatic Enzymes After Gastrectomy Trial
Phase 3 · Klinik für Allgemein- und Viszeralchirurgie, Universitätskli · University of Leipzig · NCT06058442 A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced
Phase 1/Phase 2 · Universitaetsklinikum Ulm · BioNTech SE · NCT07186842 International HIT-MED Registry (I-HIT-MED)
Phase N/A · University Hospital Ulm · Universitätsklinikum Hamburg-Eppendorf · NCT02417324 A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathie
Phase 3 · University of Ulm · Pfizer · NCT05895786

Look up another city

Look up another condition